Works matching AU Zhuchen Yan


Results: 5
    1
    2
    3
    4
    5

    Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis.

    Published in:
    Gastric Cancer, 2024, v. 27, n. 5, p. 1046, doi. 10.1007/s10120-024-01516-3
    By:
    • Kang, Yoon-Koo;
    • Qin, Shukui;
    • Lee, Keun-Wook;
    • Oh, Sang Cheul;
    • Kim, In-Ho;
    • Kim, Jong Gwang;
    • Li, Yong;
    • Yan, Zhuchen;
    • Li, Jin;
    • Bai, Li-Yuan;
    • Chan, Catherine;
    • Yusuf, Akeem;
    • Zahlten-Kümeli, Anita;
    • Taylor, Kate;
    • Yamaguchi, Kensei
    Publication type:
    Article